Published guidance, NICE advice and quality standards | Guidance

Showing 501 to 510 of 1113

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies	TA786	27 April 2022	27 April 2022
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable	TA787	27 April 2022	27 April 2022
Liposuction for chronic lymphoedema	IPG723	27 April 2022	27 April 2022
Epilepsies in children, young people and adults	NG217	27 April 2022	27 April 2022
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer	TA784	20 April 2022	20 April 2022
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)	TA785	20 April 2022	20 April 2022
Elosulfase alfa for treating mucopolysaccharidosis type 4A	HST19	20 April 2022	20 April 2022
Intramedullary distraction for upper limb lengthening	IPG722	20 April 2022	20 April 2022
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults	NG215	20 April 2022	20 April 2022
Daratumumab monotherapy for treating relapsed and refractory multiple myeloma	TA783	13 April 2022	13 April 2022